ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT May Lower Prostate Cancer Risk and Severity
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 87914" data-attributes="member: 2624"><p>Hypogonadal men who receive testosterone replacement therapy (TRT) may have a lower incidence of prostate cancer (PCa) than those not receiving TRT, according to study findings presented at the Sexual Medicine Society of North America 18[SUP]<span style="font-size: 10px">th</span>[/SUP] Annual Fall Scientific Meeting in San Antonio, Texas. In addition, PCa diagnosed in TRT recipients is less severe than PCa diagnosed in men unexposed to TRT.</p><p></p><ul> <li data-xf-list-type="ul">Urologists in Bremerhaven, Germany, and colleagues studied 400 hypogonadal men (testosterone level of 350 ng/dL or less) who received testosterone undecanoate 1000 mg every 3 months for up to 10 years and 376 hypogonadal men who opted against TRT (control group).</li> <li data-xf-list-type="ul">During a median follow-up of 8 years, 9 men in the TRT group (2.3%) were diagnosed with PCa compared with 26 (6.9%) in the control group. The incidence was 31 per 10,000 years in the TRT group compared with 95 per 10,000 years in the control group.</li> </ul><p></p><p>"Testosterone Therapy May Lower Prostate Cancer Incidence," <em>Renal and Urology News, </em>14 November 2017, <a href="http://www.renalandurologynews.com/prostate-cancer/prostate-cancer-risk-lower-with-testosterone-replacement-therapy/article/707168/" target="_blank">http://www.renalandurologynews.com/prostate-cancer/prostate-cancer-risk-lower-with-testosterone-replacement-therapy/article/707168/</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 87914, member: 2624"] Hypogonadal men who receive testosterone replacement therapy (TRT) may have a lower incidence of prostate cancer (PCa) than those not receiving TRT, according to study findings presented at the Sexual Medicine Society of North America 18[SUP][SIZE=2]th[/SIZE][/SUP] Annual Fall Scientific Meeting in San Antonio, Texas. In addition, PCa diagnosed in TRT recipients is less severe than PCa diagnosed in men unexposed to TRT. [LIST] [*]Urologists in Bremerhaven, Germany, and colleagues studied 400 hypogonadal men (testosterone level of 350 ng/dL or less) who received testosterone undecanoate 1000 mg every 3 months for up to 10 years and 376 hypogonadal men who opted against TRT (control group). [*]During a median follow-up of 8 years, 9 men in the TRT group (2.3%) were diagnosed with PCa compared with 26 (6.9%) in the control group. The incidence was 31 per 10,000 years in the TRT group compared with 95 per 10,000 years in the control group. [/LIST] "Testosterone Therapy May Lower Prostate Cancer Incidence," [I]Renal and Urology News, [/I]14 November 2017, [URL]http://www.renalandurologynews.com/prostate-cancer/prostate-cancer-risk-lower-with-testosterone-replacement-therapy/article/707168/[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TRT May Lower Prostate Cancer Risk and Severity
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top